Metabolomics,Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression profiling of hypoxic HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells: time course

ABSTRACT: Analysis of expression changes of cultured HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells subjected to hypoxia (0.5% O2) for 0, 4, 8, 12 hours . Results provide insight to cell type-specific response to hypoxia. HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells were collected under normoxic conditions (~19% O2, 0 hours) and after 4, 8 and 12 hours of hypoxia treatment (0.5% O2). For each cell line, three replicates of total RNA at each time point were prepared using Trizol and submitted to the DFCI Microarray Core for labeling, hybridization to Affymetrix HG-U133Plus2 oligonucleotide arrays and image scanning.

ORGANISM(S): Homo sapiens

SUBMITTER: Xiaobo Xia 

PROVIDER: E-GEOD-18494 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Json Xml
altmetric image

Publications

Preferential binding of HIF-1 to transcriptionally active loci determines cell-type specific response to hypoxia.

Xia Xiaobo X   Kung Andrew L AL  

Genome biology 20091014 10

<h4>Background</h4>Hypoxia-inducible factor 1 (HIF-1) plays a key role in cellular adaptation to hypoxia. To better understand the determinants of HIF-1 binding and transactivation, we used ChIP-chip and gene expression profiling to define the relationship between the epigenetic landscape, sites of HIF-1 binding, and genes transactivated by hypoxia in two cell lines.<h4>Results</h4>We found that when cells were acutely subjected to hypoxia, HIF-1 preferentially bound to loci that were already tr  ...[more]

Similar Datasets

Unknown Expression profiling of hypoxic HepG2 hepatoma, U87 glioma, and MDA-MB231 breast cancer cells: time course
2009-10-09 | GSE18494 | GEO
Genomics,Multiomics Homo sapiens
| PRJNA123717 | ENA
Unknown Genome-wide HIF-1, RNA polII, and H3K4me3 binding sites in U87 and HepG2 cells
2009-10-09 | GSE18499 | GEO
Genomics,Multiomics
| PRJNA120255 | ENA
Unknown Breast cancer cell lines treated with mebedazole (an FDA-approved anti-parasitic) under 20% or 1% oxygen conditions.
2023-01-23 | GSE222702 | GEO
Transcriptomics Expression data from transfection of SW1783 and U87 glioma cells with miR-376a* for 24 and 72 hours
2012-05-31 | E-GEOD-34482 | biostudies-arrayexpress
Unknown Regulation of chromatin accessibility in hypoxia condition
2023-03-05 | GSE200757 | GEO
Transcriptomics Expression data from U87 glioma cells and U87-2M1 glioma cells
2012-12-31 | E-GEOD-35169 | biostudies-arrayexpress
Transcriptomics Knock-down and Over-expression of JMJD6 in MCF-7 and/or MDA-MB231
2012-05-09 | E-GEOD-31782 | biostudies-arrayexpress
Transcriptomics Effect of PIAS1 on gene expression
2014-02-06 | E-GEOD-44024 | biostudies-arrayexpress